1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification (
- Outpatient specialist clinics for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the Nordic countries (
- Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy : a registry-based study (
- 2019
- Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension (
- Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension (
- 2016
- Versican accumulates in vascular lesions in pulmonary arterial hypertension (